Apoorva Sarode

Apoorva Sarode

Auto-generated profile, based on publicly available information

Apoorva Sarode

Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., South San Francisco, California 94080, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2023 in ACS Nano
Verified
Journal Article
Open access
MHMichal Hammel
Michal Hammel
YFYuchen Fan
Yuchen Fan
ASApoorva Sarode
Apoorva Sarode
ABAmy E. Byrnes
Amy E. Byrnes
NZNanzhi Zang
Nanzhi Zang
GHGreg L. Hura
Greg L. Hura
With three FDA-approved products, lipid nanoparticles (LNPs) are under intensive development for delivering wide-ranging nucleic acid therapeutics. A significant challenge for LNP development is insufficient understanding of structure-activity relationship (SAR). Small changes in chemical composition and process parameters can affect LNP structure, significantly impacting performance in vitro and in vivo. The choice of polyethylene glycol lipid (PEG-lipid), one of the essential lipids for LNP, has been proven to govern particle size. Here we find that PEG-lipids can further modify the core organization of antisense oligonucleotide (ASO)-loaded LNPs to govern its gene silencing activity. Furthermore, we also have found that the extent of compartmentalization, measured by the ratio of disordered vs ordered inverted hexagonal phases within an ASO-lipid core, is predictive of in vitro gene silencing. In this work, we propose that a lower ratio of disordered/ordered core phases correlates with stronger gene knockdown efficacy. To establish these findings, we developed a seamless high-throughput screening approach that integrated an automated LNP formulation system with structural analysis by small-angle X-ray scattering (SAXS) and in vitro TMEM106b mRNA knockdown assessment. We applied this approach to screen 54 ASO-LNP formulations while varying the type and concentration of PEG-lipids. Representative formulations with diverse SAXS profiles were further visualized using cryogenic electron microscopy (cryo-EM) to help structural elucidation. The proposed SAR was built by combining this structural analysis with in vitro data. Our integrated methods, analysis, and resulting findings on PEG-lipid can be applied to rapidly optimize other LNP formulations in a complex design space.

31 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
YGYongsheng Gao
Yongsheng Gao
ASApoorva Sarode
Apoorva Sarode
NKNikolaos Kokoroskos
Nikolaos Kokoroskos
AUAnvay Ukidve
Anvay Ukidve
ZZZongmin Zhao
Zongmin Zhao
SMSamir Mitragotri
Samir Mitragotri
The study describes a synthetic hemostatic agent that can be intravenously injected to reduce internal hemorrhage.

18 July 2023 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
MLMatthew N. O'Brien Laramy
Matthew N. O'Brien Laramy
ACAntonio P. Costa
Antonio P. Costa
YCYareli Maciel Cebrero
Yareli Maciel Cebrero
JJJohnson Joseph
Johnson Joseph
ASApoorva Sarode
Apoorva Sarode
GHGreg L. Hura
Greg L. Hura

4 February 2022 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
ASApoorva Sarode
Apoorva Sarode
YFYuchen Fan
Yuchen Fan
ABAmy E. Byrnes
Amy E. Byrnes
MHMichal Hammel
Michal Hammel
GHGreg L. Hura
Greg L. Hura
CYChun-Wan Yen
Chun-Wan Yen
Lipid nanoparticles (LNPs) are gaining traction in the field of nucleic acid delivery following the success of two mRNA vaccines against COVID-19. As one of the constituent lipids on LNP surfaces, PEGylated lipids (PEG-lipids) play an important role in defining LNP physicochemical properties and biological interactions. Previous studies indicate that LNP performance is modulated by tuning PEG-lipid parameters including PEG size and architecture, carbon tail type and length, as well as the PEG-lipid molar ratio in LNPs. Owing to these numerous degrees of freedom, a high-throughput approach is necessary to fully understand LNP behavioral trends over a broad range of PEG-lipid variables. To this end, we report a low-volume, automated, high-throughput screening (HTS) workflow for the preparation, characterization, and in vitro assessment of LNPs loaded with a therapeutic antisense oligonucleotide (ASO). A library of 54 ASO-LNP formulations with distinct PEG-lipid compositions was prepared using a liquid handling robot and assessed for their physiochemical properties as well as gene silencing efficacy in murine cortical neurons. Our results show that the molar ratio of anionic PEG-lipid in LNPs regulates particle size and PEG-lipid carbon tail length controls ASO-LNP gene silencing activity. ASO-LNPs formulated using PEG-lipids with optimal carbon tail lengths achieved up to 5-fold lower mRNA expression in neurons as compared to naked ASO. Representative ASO-LNP formulations were further characterized using dose–response curves and small-angle X-ray scattering to understand structure–activity relationships. Identified hits were also tested for efficacy in primary murine microglia and were scaled-up using a microfluidic formulation technique, demonstrating a smooth translation of ASO-LNP properties and in vitro efficacy. The reported HTS workflow can be used to screen additional multivariate parameters of LNPs with significant time and material savings, therefore guiding the selection and scale-up of optimal formulations for nucleic acid delivery to a variety of cellular targets.

20 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ADAnshuman Dasgupta
Anshuman Dasgupta
TSTao Sun
Tao Sun
RPRoberto Palomba
Roberto Palomba
ERElena Rama
Elena Rama
YZYongzhi Zhang
Yongzhi Zhang
Twan LammersTwan Lammers
Twan Lammers
Surface tension provides microbubbles (MB) with a perfect spherical shape. Here, we demonstrate that MB can be engineered to be nonspherical, endowing them with unique features for biomedical applications. Anisotropic MB were generated via one-dimensionally stretching spherical poly(butyl cyanoacrylate) MB above their glass transition temperature. Compared to their spherical counterparts, nonspherical polymeric MB displayed superior performance in multiple ways, including i) increased margination behavior in blood vessel–like flow chambers, ii) reduced macrophage uptake in vitro, iii) prolonged circulation time in vivo, and iv) enhanced blood–brain barrier (BBB) permeation in vivo upon combination with transcranial focused ultrasound (FUS). Our studies identify shape as a design parameter in the MB landscape, and they provide a rational and robust framework for further exploring the application of anisotropic MB for ultrasound-enhanced drug delivery and imaging applications.

21 March 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
APAnna Pratsinis
Anna Pratsinis
YFYuchen Fan
Yuchen Fan
MPMichaela Portmann
Michaela Portmann
MHMichal Hammel
Michal Hammel
PKPonien Kou
Ponien Kou
MKMichael Keller
Michael Keller